However, from an anti-inflammatory point of view, this reduction of both IL-1β and IL-6 could explain the hypothesis, proposed by Borokivova46, according to which ACh levels decrease can favor neuroinflammatory events, as observed in Alzheimer disease. This evidence concerns the gene IL6 and Alzheimer disease.